Delivery Order SPE2DB20D2002-SPE2DB25FL43X

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,012.20, is for the delivery of 4,567,909,359 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,839 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine, with a total ceiling value of $1,347.50. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds...
This is a $1,749.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML medical supplies, with a completion date of January 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,906,226 units of the HAVRIX 720 0.5 ML syringe vaccine. The contract has a ceiling value of $2,309.50 and a period of performance through March 11, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.27 contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The award has a completion date of May 20, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.87 firm fixed-price contract is for the delivery of 4,567,982,890 units of the HAVRIX 720 vaccine syringe. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,467.81 and a period of performance through January 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.66, is for the supply of HAVRIX 720 unit/0.5 mL syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $1,027.23 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for HAVRIX 1,440 UNIT/ML syringes and has an ultimate completion date of April 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,589,853 units of the HAVRIX 720 immunization vaccine in 0.5 mL syringes. The $4,676.40 firm-fixed-price contract was awarded on May 13, 2024 by the Defense Logistics Agency (DLA), a defense agency, for fulfillment by May 14, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL43X
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,333 units of the HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML vaccine, with a ceiling value of $6,073.20. The contract is not set-aside and has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader efforts to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/24/25, 12:55 AM